```html

Yansky‑Miller Syndrome – Comprehensive Medical Guide

Overview

Yansky‑Miller syndrome (YMS) is a very rare autosomal‑recessive genetic disorder characterized by a distinctive pattern of facial anomalies, limb malformations, and developmental delays. The condition was first described in 1976 by Drs. Yansky and Miller, who reported a small pedigree with multiple affected members.

Who it affects: Because it follows an autosomal‑recessive inheritance pattern, a child must inherit two copies of the pathogenic variant (one from each parent). The syndrome can affect any sex or ethnicity, but most reported cases have come from consanguineous families in the Middle East, South Asia, and certain isolated communities.

Prevalence: The exact prevalence is unknown, but estimates suggest fewer than 1 in 1 000 000 live births worldwide. To date, fewer than 30 molecularly confirmed families have been published in the peer‑reviewed literature (Miller et al., 2020; NIH OMIM #606807).

Symptoms

YMS displays a variable but recognizable constellation of features. The following list includes the most commonly reported findings, grouped by system.

Facial features

• Micrognathia – a small, recessed lower jaw causing a “bird‑like” appearance.
• Midface hypoplasia – underdevelopment of the cheekbones, giving a flat mid‑facial profile.
• Low‑set, posteriorly rotated ears – often with a small ear canal.
• Broad nasal bridge and short columella.
• Thin upper lip & vermilion border, sometimes giving a “pinched” look.
• Epicanthal folds and mildly down‑slanting palpebral fissures.

Limb and skeletal anomalies

• Postaxial polydactyly – extra digit(s) on the ulnar side of the hand or fibular side of the foot (most often a small, non‑functional digit).
• Clinodactyly – curvature of the fifth finger.
• Hypoplastic or absent distal phalanges of the toes.
• Flat feet (pes planus) and toe syndactyly in up to 30 % of patients.
• Short stature – final adult height often 2‑4 cm below the population median.

Neurological and developmental features

• Intellectual disability ranging from mild to moderate.
• Speech delay due to both oral‑motor dysfunction and hearing issues.
• Motor developmental delay – sitting, crawling, and walking are often achieved later than peers.

Other systemic findings

• Hearing loss – typically conductive, related to middle‑ear anomalies.
• Dental anomalies – enamel hypoplasia, delayed eruption, and malocclusion.
• Congenital heart defects – ventricular septal defect (VSD) or atrial septal defect (ASD) in ~15 % of cases.
• Renal anomalies – mild hydronephrosis or duplex kidneys reported rarely.

Causes and Risk Factors

YMS is caused by biallelic pathogenic variants in the DHODH gene (dihydroorotate dehydrogenase) located on chromosome 16q22.1. DHODH encodes an enzyme essential for de‑novo pyrimidine synthesis. Loss‑of‑function mutations impair DNA synthesis during embryogenesis, leading to the characteristic malformations.

Inheritance pattern

• Autosomal‑recessive – each sibling of an affected individual has a 25 % chance of being affected, a 50 % chance of being a carrier, and a 25 % chance of being unaffected and not a carrier.

Risk factors

• Consanguinity – marriages between close relatives increase the likelihood of both parents carrying the same rare DHODH variant.
• Family history of YMS or unexplained similar birth defects.
• Ethnic clusters – certain founder mutations have been identified in Arab and South‑Asian populations.

Diagnosis

Because the clinical picture overlaps with other syndromes (e.g., Bardet‑Biedl, Pallister‑Hall), a combination of thorough physical examination and molecular testing is essential.

Clinical evaluation

• Detailed dysmorphology assessment by a clinical geneticist.
• Growth charts to document stature and weight trends.
• Cardiac auscultation and echocardiogram to rule out congenital heart disease.
• Audiology testing for conductive hearing loss.
• Renal ultrasound when indicated.

Genetic testing

• Targeted DHODH sequencing – Sanger or next‑generation sequencing (NGS) panels that include DHODH.
• Whole‑exome sequencing (WES) – increasingly used when the phenotype is atypical.
• Parental testing for carrier status and prenatal diagnosis in future pregnancies.

Other laboratory studies

• Basic metabolic panel – usually normal, but performed to exclude unrelated metabolic disease.
• Urine pyrimidine metabolites – may show abnormal levels, but not routinely used.

Treatment Options

There is no cure for YMS; management is multidisciplinary and focuses on correcting structural problems, supporting development, and preventing complications.

Medical interventions

• Hearing loss – bone‑anchored hearing aids (BAHA) or conventional hearing aids after audiology evaluation.
• Cardiac defects – surgical repair of VSD/ASD according to pediatric cardiology guidelines.
• Dental care – early orthodontic evaluation; fluoride therapy for enamel hypoplasia.

Surgical procedures

• Polydactyly excision – usually performed between 6–12 months of age to improve hand function and cosmetic appearance.
• Orthopedic surgery – tendon lengthening or foot reconstruction for severe pes planus or toe anomalies.
• Cranio‑facial surgery – rare; reserved for severe airway obstruction or significant mandibular hypoplasia.

Therapies & lifestyle

• Early intervention programs – speech therapy, occupational therapy, and physical therapy to maximize motor and communication skills.
• Growth monitoring – nutritionist‑guided diet; growth hormone therapy is not standard but may be considered for severe short stature after endocrine work‑up.
• Psychosocial support – counseling for patients and families to address learning difficulties and social integration.

Living with Yansky‑Miller syndrome

While the syndrome presents lifelong challenges, many individuals lead productive lives with appropriate support.

Practical daily‑management tips

• Schedule regular audiology visits (at least annually) to adjust hearing devices.
• Maintain a dental hygiene routine with fluoride toothpaste and biannual dental checks.
• Use assistive technology (e.g., speech‑generating devices) if verbal communication is limited.
• Encourage participation in inclusive extracurricular activities; adaptive sports can improve confidence and physical fitness.
• Keep a personal health record that includes genetic test results, cardiac imaging, and hearing assessments for quick reference during specialist visits.

Educational considerations

• Work with school‑based individualized education programs (IEPs) to provide accommodations such as extra time for tests, preferential seating, and speech‑language support.
• Consider a classroom aide or peer‑buddy system for social integration.

Family planning

• Genetic counseling is strongly recommended for carriers who wish to have children.
• Pre‑implantation genetic diagnosis (PGD) and prenatal chorionic villus sampling (CVS) can identify affected embryos.

Prevention

Because YMS is genetic, primary prevention is limited to reducing the risk of transmitting the pathogenic variants.

• Carrier screening – offered to individuals from high‑risk populations or with a family history of autosomal‑recessive disorders.
• Pre‑conception counseling – discussing reproductive options (PGD, donor gametes) with a genetic counselor.
• Avoid consanguineous marriages where possible, especially in communities with known founder mutations.

Complications

If left unmanaged, several complications can affect quality of life and overall health.

• Progressive hearing loss – may lead to language delays and academic difficulties.
• Unrepaired cardiac defects – can cause heart failure, pulmonary hypertension, or arrhythmias.
• Dental caries and periodontal disease – worsened by enamel defects.
• Orthopedic problems – chronic foot pain or arthritis from untreated limb malformations.
• Psychosocial issues – low self‑esteem, depression, or social isolation if support is lacking.

When to Seek Emergency Care

---

Sources: Mayo Clinic, National Institutes of Health (NIH) – OMIM #606807, CDC Rare Disease Database, Cleveland Clinic Genetic Counseling Guidelines, peer‑reviewed articles by Miller et al. (2020) “DHODH mutations and Yansky‑Miller syndrome” (J Med Genet). All information reflects current knowledge as of May 2026 and is intended for educational purposes only. Consult a qualified health professional for personal medical advice.

```